1-氯-5-硝基萘 | 605-63-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 1-氯-5-硝基萘
• 英文名称: 1-chloro-5-nitronaphthalene
• 英文别名: 1-nitro-5-chloronaphthalene；1-chloro-5-nitro-naphthalene；1-Chlor-5-nitro-naphthalin；1-Chlor-5-nitronaphthalin
• CAS: 605-63-0
• 化学式: C₁₀H₆ClNO₂
• 分子量: 207.616
• InChiKey: ASXDLWJNLAXOEA-UHFFFAOYSA-N

物化性质

• 熔点：
  111°C
• 沸点：
  342.8±17.0 °C(Predicted)
• 密度：
  1.3190 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2904909090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Chloro-5-nitronaphthalene
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Chloro-5-nitronaphthalene
CAS number: 605-63-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H6ClNO2
Molecular weight: 207.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-氯-5-硝基萘 在 potassium carbonate 作用下， 以 二甲基亚砜 、 甲苯 为溶剂， 反应 19.0h， 生成 C₃₀H₂₃N₇O₄
  参考文献：
  名称：

  含腺嘌呤结构的芳香族二胺及其制备方法和 含腺嘌呤结构的聚酰亚胺及其制备方法

  摘要：

  本发明公开了一种含腺嘌呤结构的芳香族二胺及其制备方法和含腺嘌呤结构的聚酰亚胺及其制备方法，本发明以无毒无害的腺嘌呤为原料，能衍生出大量可用于聚合物合成的生物基单体，使所得的聚合物符合可持续发展的资源节约性要求。本发明为聚酰亚胺的单体来源提供了基于生物质的新路径，缓解了聚酰亚胺材料对石油资源的依赖程度。

  公开号：

  CN106432240B
• 作为产物：
  描述：

  硝基萘 在 三氯异氰尿酸 、 二乙基[4-[[4-(二乙基氨基)苯基]苯基亚甲基]-2,5-环己二烯-1-亚基]铵 作用下， 以 乙腈 为溶剂， 反应 24.0h， 以63%的产率得到1-氯-5-硝基萘
  参考文献：
  名称：

  三氯异氰尿酸（TCCA）通过催化有机染料活化来扩增芳烃和杂芳烃的氯化反应性

  摘要：

  使用三氯异氰尿酸（TCCA）和催化艳绿（BG）以良好至极佳的收率（可缩放至克级）对含有吸电子基团的杂芳烃和芳烃进行氯化处理。BG的可见光活化可增强TCCA的亲电性质，为失活的（杂）芳族底物的酸促进氯化提供了温和的替代方法。通过与其他氯化试剂进行比较以及对包括咖啡因，利多卡因和非那酮在内的药物进行氯化，证明了TCCA / BG系统的实用性。

  DOI：

  10.1021/acs.orglett.9b01414
• 作为试剂：
  描述：

  1-氯-8-硝基萘 在 1-氯-5-硝基萘 作用下， 生成 4-chloro-5-nitro-naphthalene-1-sulfonic acid
  参考文献：
  名称：

  DE103980

  摘要：

  公开号：

文献信息

• Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
  申请人：——

  公开号：US20040077605A1

  公开（公告）日：2004-04-22

  Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

  融合的环化合物，使用这种化合物治疗与核激素受体相关的疾病，如癌症和免疫紊乱的方法，以及含有这种化合物的药物组合物。
• METHOD FOR THE PREPARATION OF FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF
  申请人：Salvati E. Mark

  公开号：US20050119228A1

  公开（公告）日：2005-06-02

  Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

  融合的环化合物，使用这种化合物治疗与核激素受体相关的疾病，如癌症和免疫紊乱的方法，以及含有这种化合物的药物组合物。
• Direct Cyanation of Picolinamides Using K₄[Fe(CN)₆] as the Cyanide Source
  作者：Dinghui Guan、Lu Han、Lulu Wang、He Song、Wenyi Chu、Zhizhong Sun

  DOI：10.1246/cl.150111

  日期：2015.6.5

  The efficient, simple, and environment-friendly route of direct cyanation of picolinamides has been developed with nontoxic K4[Fe(CN)6] as the cyanide source through Pd-catalyzed C–H bond activatio...

  以无毒的K4[Fe(CN)6]为氰化物源，通过Pd催化的C-H键活化，开发了一种高效、简单、环保的吡啶甲酰胺直接氰化路线。
• [EN] QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF<br/>[FR] COMPOSÉS DE QUINAZOLINE, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
  申请人：INVENTISBIO CO LTD

  公开号：WO2022002102A1

  公开（公告）日：2022-01-06

  Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (II), or Formula (III), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer or endometrial cancer.

  本文提供了新颖的化合物，例如具有化学式(I)、化学式(II)或化学式(III)的化合物，或其药用可接受的盐。本文还提供了制备这些化合物的方法以及使用这些化合物的方法，例如，在癌细胞中抑制KRAS G12D，以及治疗各种癌症，如胰腺癌、结肠癌、肺癌或子宫内膜癌。
• [EN] HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROARYLE, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
  申请人：INVENTISBIO CO LTD

  公开号：WO2022042630A1

  公开（公告）日：2022-03-03

  Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (A), Formula (II), Formula (III), Formula (IV), or Formula (V), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer (e.g., non-small cell lung cancer) or endometrial cancer.

  本文提供了新颖的化合物，例如具有公式（I），公式（A），公式（II），公式（III），公式（IV）或公式（V）的化合物或其药学上可接受的盐。本文还提供了制备这些化合物的方法和使用这些化合物的方法，例如在癌细胞中抑制KRAS G12D，和/或治疗各种癌症，如胰腺癌，结直肠癌，肺癌（例如非小细胞肺癌）或子宫内膜癌。